Submitted:
17 June 2026
Posted:
17 June 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Soil Sampling, Isolation and Identification of A. fumigatus
2.2. Susceptibility of A. fumigatus Isolates and cyp51A Gene Sequencing
2.3. cyp51A Gene Mutation Analysis and Phylogenetic Analysis
2.4. Data Analysis
3. Results
3.1. Isolation and Susceptibility of A. fumigatus Isolates
3.2. cyp51A Polymorphism and Correlation of Mutation Sites with Triazole MICs
3.3. cyp51A Amino Acid Substitution and Phylogenetic Analysis
4. Discussion
4.1. Extremely Low Prevalence of Triazole Resistance and Absence of Resistant A. fumigatus Strains
4.2. Non-Azole-Resistance Mutation Sites in the cyp51A Gene
4.3. Widespread Distribution of the CYP51A Mutations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| ARAF | azole-resistant A. fumigatus |
| ITR | itraconazole |
| VOR | voriconazole |
| MIC | minimum inhibitory concentration |
References
- Latgé, J.-P.; Chamilos, G. Aspergillus fumigatus and Aspergillosis in 2019. Clin. Microbiol. Rev. 2019, 33, 10.1128/cmr. 00140–00118. [Google Scholar] [CrossRef] [PubMed]
- Gong, J.; Huang, J.; Liu, Y.; Zhang, Y.; Gao, Y. Unveiling environmental transmission risks: Comparative analysis of azole resistance in Aspergillus fumigatus clinical and environmental isolates from Yunnan, China. Microbiol. Spectr. 2024, 12, e01594-01524. [Google Scholar] [CrossRef] [PubMed]
- Kordana, N.; Johnson, A.; Quinn, K.; Obar, J.J.; Cramer, R.A. Recent developments in Aspergillus fumigatus research: diversity, drugs, and disease. Microbiol. Mol. Bio. Revi. 2025, 89, e00011-00023. [Google Scholar] [CrossRef] [PubMed]
- Zhou, D.; Liu, Y.; Zhang, Q.; Zhang, Y.; Xu, J. Novel Genetic Diversity and Geographic Structures of Aspergillus fumigatus (Order Eurotiales, Family Aspergillaceae) in the Karst Regions of Guizhou, China. Microorganisms 2026, 14, 237. [Google Scholar] [CrossRef] [PubMed]
- O’Gorman, C.M. Airborne Aspergillus fumigatus conidia: a risk factor for aspergillosis. Fungal Biol. Rev. 2011, 25, 151–157. [Google Scholar] [CrossRef]
- Croft, C.A.; Culibrk, L.; Moore, M.M.; Tebbutt, S.J. Interactions of Aspergillus fumigatus conidia with airway epithelial cells: a critical review. Front. Microbiol. 2016, 7, 472. [Google Scholar] [CrossRef]
- Ashu, E.E.; Hagen, F.; Chowdhary, A.; Meis, J.F.; Xu, J. Global population genetic analysis of Aspergillus fumigatus. mSphere 2017, 2. [Google Scholar] [CrossRef] [PubMed]
- Kosmidis, C.; Denning , D.W. Republished: the clinical spectrum of pulmonary aspergillosis . Postgrad. Med. J. 2015, 91, 403–410. [Google Scholar] [CrossRef]
- Sewell, T.R.; Zhu, J.; Rhodes, J.; Hagen, F.; Meis, J.F.; Fisher, M.C.; Jombart, T. Nonrandom distribution of azole resistance across the global population of Aspergillus fumigatus. mBio 2019, 10. [Google Scholar] [CrossRef] [PubMed]
- Wiederhold, N.P. The antifungal arsenal: alternative drugs and future targets. Int. J. Antimicro. Agents 2018, 51, 333–339. [Google Scholar] [CrossRef] [PubMed]
- Mroczyńska, M.; Kurzyk, E.; Śliwka-Kaszyńska, M.; Nawrot, U.; Adamik, M.; Brillowska-Dąbrowska, A. The effect of posaconazole, itraconazole and voriconazole in the culture medium on Aspergillus fumigatus triazole resistance. Microorganisms 2020, 8, 285. [Google Scholar] [CrossRef] [PubMed]
- Meis, J.F.; Chowdhary, A.; Rhodes, J.L.; Fisher, M.C.; Verweij, P.E. Clinical implications of globally emerging azole resistance in Aspergillus fumigatus. Philos. Trans. R. Soc. B Biol. Sci. 2016, 371. [Google Scholar] [CrossRef] [PubMed]
- Morrissey, C.O.; Kim, H.Y.; Duong, T.-M.N.; Moran, E.; Alastruey-Izquierdo, A.; Denning, D.W.; Perfect, J.R.; Nucci, M.; Chakrabarti, A.; Rickerts, V. Aspergillus fumigatus—a systematic review to inform the World Health Organization priority list of fungal pathogens. Med. Mycol. 2024, 62, myad129. [Google Scholar] [CrossRef] [PubMed]
- Ballard, E.; Melchers, W.J.; Zoll, J.; Brown, A.J.; Verweij, P.E.; Warris, A. In-host microevolution of Aspergillus fumigatus: A phenotypic and genotypic analysis. Fungal Genet. Biol. 2018, 113, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Denning, D.; Radford, S.; Oakley, K.; Hall, L.; Johnson, E.; Warnock, D. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J. Antimicrob. Chemother. 1997, 40, 401–414. [Google Scholar] [CrossRef] [PubMed]
- Chowdhary, A.; Meis, J.F. Emergence of azole resistant Aspergillus fumigatus and One Health: time to implement environmental stewardship. Environ. Microbiol. 2018, 20, 1299–1301. [Google Scholar] [CrossRef] [PubMed]
- Zhou, D.; Korfanty, G.A.; Mo, M.; Wang, R.; Li, X.; Li, H.; Li, S.; Wu, J.-Y.; Zhang, K.-Q.; Zhang, Y. Extensive genetic diversity and widespread azole resistance in greenhouse populations of Aspergillus fumigatus in Yunnan, China. mSphere 2021, 6, 10.1128/msphere. 00066–00021. [Google Scholar] [CrossRef] [PubMed]
- Resendiz Sharpe, A.; Lagrou, K.; Meis, J.F.; Chowdhary, A.; Lockhart, S.R.; Verweij, P.E.; Group, I.E.A.R.S.W. Triazole resistance surveillance in Aspergillus fumigatus. Med. Mycol. 2018, 56, S83–S92. [Google Scholar] [CrossRef] [PubMed]
- Chen, S.; Zhu, G.; Lin, H.; Guo, J.; Deng, S.; Wu, W.; Goldman, G.H.; Lu, L.; Zhang, Y. Variability in competitive fitness among environmental and clinical azole-resistant Aspergillus fumigatus isolates. mBio 2024, 18 15, e00263-00224. [Google Scholar] [CrossRef]
- Wiederhold, N.P.; Verweij, P.E. Aspergillus fumigatus and pan-azole resistance: who should be concerned? Curr. Opin. Infect. Dis. 2020, 33, 290–297. [Google Scholar] [CrossRef] [PubMed]
- Chowdhary, A.; Sharma, C.; Meis, J.F. Azole-resistant aspergillosis: epidemiology, molecular mechanisms, and treatment. J. Infect. Dis. 2017, 216, S436–S444. [Google Scholar] [CrossRef] [PubMed]
- Albarrag, A.M.; Anderson, M.J.; Howard, S.J.; Robson, G.D.; Warn, P.A.; Sanglard, D.; Denning, D.W. Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter. Antimicrob. Agents Chemother. 2011, 55, 5113–5121. [Google Scholar] [CrossRef] [PubMed]
- Bader, O.; Weig, M.; Reichard, U.; Lugert, R.; Kuhns, M.; Christner, M.; Held, J.; Peter, S.; Schumacher, U.; Buchheidt, D. cyp51A-based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany. Antimicrob. Agents Chemother. 2013, 57, 3513–3517. [Google Scholar] [CrossRef] [PubMed]
- Lescar, J.; Meyer, I.; Akshita, K.; Srinivasaraghavan, K.; Verma, C.; Palous, M.; Mazier, D.; Datry, A.; Fekkar, A. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole. J. Antimicrob. Chemother. 2014, 69, 3244–3247. [Google Scholar] [CrossRef] [PubMed]
- Pérez-Cantero, A.; López-Fernández, L.; Guarro, J.; Capilla, J. Azole resistance mechanisms in Aspergillus: update and recent advances. Int. J. Antimicrob. Agents 2020, 55, 105807. [Google Scholar] [CrossRef] [PubMed]
- Snelders, E.; Camps, S.M.; Karawajczyk, A.; Rijs, A.J.; Zoll, J.; Verweij, P.E.; Melchers, W.J. Genotype–phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus. Fungal Genet. Bio. 2015, 82, 129–135. [Google Scholar] [CrossRef] [PubMed]
- Wiederhold, N.P.; Gil, V.G.; Gutierrez, F.; Lindner, J.R.; Albataineh, M.T.; McCarthy, D.I.; Sanders, C.; Fan, H.; Fothergill, A.W.; Sutton, D.A. First detection of TR34 L98H and TR46 Y121F T289A Cyp51 mutations in Aspergillus fumigatus isolates in the United States. J. Clin. Microbiol. 2016, 26 54, 168–171. [Google Scholar] [CrossRef] [PubMed]
- Tan, X.T.; Mokhtar, N.N.B.; Hii, S.Y.F.; Amran, F. Antifungal Susceptibility and Genotypic Analysis of cyp51A Mutations in Aspergillus fumigatus Isolates in Malaysia. Infect. Drug Resist. 2024, 2159–2168. [Google Scholar] [CrossRef] [PubMed]
- Zhang, N.; Castlebury, L.A.; Miller, A.N.; Huhndorf, S.M.; Schoch, C.L.; Seifert, K.A.; Rossman, A.Y.; Rogers, J.D.; Kohlmeyer, J.; Volkmann-Kohlmeyer, B. An overview of the systematics of the Sordariomycetes based on a four-gene phylogeny. Mycologia 2006, 98, 1076–1087. [Google Scholar] [CrossRef]
- Zhang, B.; Xiao, F.; Wu, H.; Mo, S.; Zhu, S.; Yu, L.; Xiong, K.; Lan, A. Combating the fragile karst environment in Guizhou, China. AMBIO J. Hum. Environ. 2006, 35, 94–97. [Google Scholar] [CrossRef]
- Zhou, Z.; Zhang, S.; Xiong, K.; Li, B.; Tian, Z.; Chen, Q.; Yan, L.; Xiao, S. The spatial distribution and factors affecting karst cave development in Guizhou Province. J. Geogr. Sci. 2017, 27, 1011–1024. [Google Scholar] [CrossRef]
- Zhou, D.; Wang, R.; Li, X.; Peng, B.; Yang, G.; Zhang, K.-Q.; Zhang, Y.; Xu, J. Genetic diversity and azole resistance among natural Aspergillus fumigatus populations in Yunnan, China. Microb. Ecol. 2022, 83, 869–885. [Google Scholar] [CrossRef] [PubMed]
- Zhou, D.; Gong, J.; Duan, C.; He, J.; Zhang, Y.; Xu, J. Genetic structure and triazole resistance among Aspergillus fumigatus populations from remote and undeveloped regions in Eastern Himalaya. mSphere 2023, 8, e00071-00023. [Google Scholar] [CrossRef] [PubMed]
- 33. CLSI M38. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, 3rd ed.; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2017; Available online: https://standards.globalspec.com/std/10266415/clsi-m38.
- Snelders, E.; Karawajczyk, A.; Schaftenaar, G.; Verweij, P.E.; Melchers, W.J. Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling. Antimicrob. Agents Chemother. 2010, 54, 2425–2430. [Google Scholar] [CrossRef] [PubMed]
- Mellado, E.; Diaz-Guerra, T.M.; Cuenca-Estrella, M.; Rodriguez-Tudela, J.L. Identification of two different 14-α sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J. Clin. Microbiol. 2001, 39, 2431–2438. [Google Scholar] [CrossRef] [PubMed]
- Librado, P.; Rozas, J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 2009, 25, 1451–1452. [Google Scholar] [CrossRef] [PubMed]
- Tamura, K.; Stecher, G.; Peterson, D.; Filipski, A.; Kumar, S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol. Biol. Evol. 2013, 30, 2725–2729. [Google Scholar] [CrossRef] [PubMed]
- Chen, Y.; Dong, F.; Zhao, J.; Fan, H.; Qin, C.; Li, R.; Verweij, P.E.; Zheng, Y.; Han, L. High azole resistance in Aspergillus fumigatus isolates from strawberry fields, China, 2018. Emerg. Infect. Dis. 2020, 26, 81. [Google Scholar] [CrossRef] [PubMed]
- Cao, D.; Wu, R.; Dong, S.; Wang, F.; Ju, C.; Yu, S.; Xu, S.; Fang, H.; Yu, Y. Five-year survey (2014 to 2018) of azole resistance in environmental Aspergillus fumigatus isolates from China. Antimicrob. Agents Chemother. 2020, 64. [Google Scholar] [CrossRef] [PubMed]
- Korfanty, G.; Kazerouni, A.; Dixon, M.; Trajkovski, M.; Gomez, P.; Xu, J. What in Earth? Analyses of Canadian soil populations of Aspergillus fumigatus. Can. J. Microbiol. 2024, 71, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Hurst, S.F.; Berkow, E.L.; Stevenson, K.L.; Litvintseva, A.P.; Lockhart, S.R. Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA. J. Antimicrob. Chemother. 2017, 72, 2443–2446. [Google Scholar] [CrossRef] [PubMed]
- Amona, F.M.; Oladele, R.O.; Resendiz-Sharpe, A.; Denning, D.W.; Kosmidis, C.; Lagrou, K.; Zhong, H.; Han, L. Triazole resistance in Aspergillus fumigatus isolates in Africa: a systematic review. Med. Mycol. 2022, 60, myac059. [Google Scholar] [CrossRef] [PubMed]
- Prigitano, A.; Esposto, M.C.; Romanò, L.; Auxilia, F.; Tortorano, A.M. Azole-resistant Aspergillus fumigatus in the Italian environment. J. Glob. Antimicrob. Resist. 2019, 16, 220–224. [Google Scholar] [CrossRef] [PubMed]
- Mellado, E.; Garcia-Effron, G.; Alcazar-Fuoli, L.; Cuenca-Estrella, M.; Rodriguez-Tudela, J.L. Substitutions at methionine 220 in the 14α-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob. Agents Chemother. 2004, 48, 2747–2750. [Google Scholar] [CrossRef] [PubMed]
- Escribano, P.; Recio, S.; Peláez, T.; Bouza, E.; Guinea, J. Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole. Antimicrob. Agents Chemother. 2011, 55, 2460–2462. [Google Scholar] [CrossRef] [PubMed]
- Won, E.J.; Joo, M.Y.; Lee, D.; Kim, M.-N.; Park, Y.-J.; Kim, S.H.; Shin, M.G.; Shin, J.H. Antifungal susceptibility tests and the cyp51 mutant strains among clinical Aspergillus fumigatus isolates from Korean multicenters. Mycobiology 2020, 48, 148–152. [Google Scholar] [CrossRef] [PubMed]
- Chen, Y.; Lu, Z.; Zhao, J.; Zou, Z.; Gong, Y.; Qu, F.; Bao, Z.; Qiu, G.; Song, M.; Zhang, Q. Epidemiology and molecular characterizations of azole resistance in clinical and environmental Aspergillus fumigatus isolates from China. Antimicrob. Agents Chemother. 2016, 60, 5878–5884. [Google Scholar] [CrossRef] [PubMed]
- Liu, M.; Zeng, R.; Zhang, L.; Li, D.; Lv, G.; Shen, Y.; Zheng, H.; Zhang, Q.; Zhao, J.; Zheng, N. Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China. Antimicrob. Agents Chemother. 2015, 59, 4321–4325. [Google Scholar] [CrossRef] [PubMed]
- Chen, P.; Liu, M.; Zeng, Q.; Zhang, Z.; Liu, W.; Sang, H.; Lu, L. Uncovering new mutations conferring azole resistance in the Aspergillus fumigatus cyp51A gene. Front. Microbiol. 2020, 10, 3127. [Google Scholar] [CrossRef] [PubMed]
- Hsu, T.-H.; Huang, P.-Y.; Fan, Y.-C.; Sun, P.-L. Azole resistance and cyp51A mutation of Aspergillus fumigatus in a tertiary referral hospital in Taiwan. J. Fungi 2022, 8, 908. [Google Scholar] [CrossRef] [PubMed]
- Garcia-Rubio, R.; Alcazar-Fuoli, L.; Monteiro, M.C.; Monzon, S.; Cuesta, I.; Pelaez, T.; Mellado, E. Insight into the significance of Aspergillus fumigatus cyp51A polymorphisms. Antimicrob. Agents Chemother. 2018, 62. [Google Scholar] [CrossRef] [PubMed]
- Alanio, A.; Cabaret, O.; Sitterlé, E.; Costa, J.-M.; Brisse, S.; Cordonnier, C.; Bretagne, S. Azole preexposure affects the Aspergillus fumigatus population in patients. Antimicrob. Agents Chemother. 2012, 56, 4948–4950. [Google Scholar] [CrossRef] [PubMed]
- M. Jimenez Madrid, A.; Paul, R.A.; Rotondo, F.; Deblais, L.; Rajashekara, G.; Miller, S.A.; Ivey, M.L.L. Triazole resistance in Aspergillus fumigatu s isolated from a tomato production environment exposed to propiconazole. Appl. Environ. Microbiol. 2024, 90, e00017-00024. [CrossRef] [PubMed]


| Geographical source | No. of strains | MIC (µg/mL) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Itraconazole | Voriconazole | ||||||||
| Range | GM | MIC50 | MIC90 | Range | GM | MIC50 | MIC90 | ||
| Guiyang | 22 | 0.031-0.5 | 0.142 | 0.125 | 0.25 | 0.031-0.125 | 0.053 | 0.063 | 0.063 |
| Zunyi | 21 | 0.031-0.25 | 0.074 | 0.063 | 0.125 | 0.063-0.125 | 0.099 | 0.125 | 0.125 |
| Qiannan | 21 | 0.031-0.125 | 0.05 | 0.063 | 0.125 | 0.063-0.125 | 0.079 | 0.063 | 0.125 |
| Anshun | 21 | 0.031-0.125 | 0.067 | 0.063 | 0.125 | 0.031-0.125 | 0.076 | 0.063 | 0.125 |
| Qiandongnan | 22 | 0.031-0.125 | 0.055 | 0.063 | 0.125 | 0.063-0.125 | 0.104 | 0.125 | 0.125 |
| Qianxinan | 21 | 0.015-0.25 | 0.039 | 0.031 | 0.25 | 0.063-0.25 | 0.11 | 0.125 | 0.25 |
| Liupanshui | 21 | 0.031-0.5 | 0.084 | 0.063 | 0.5 | 0.031-0.125 | 0.093 | 0.125 | 0.125 |
| Bijie | 21 | 0.031-0.125 | 0.069 | 0.063 | 0.125 | 0.031-0.25 | 0.082 | 0.063 | 0.125 |
| Tongren | 21 | 0.031-0.125 | 0.063 | 0.063 | 0.125 | 0.063-0.25 | 0.096 | 0.125 | 0.125 |
| Total | 191 | 0.015-0.5 | 0.067 | 0.063 | 0.25 | 0.031-0.25 | 0.086 | 0.063 | 0.125 |
| Geographical source | No. of strains | Number of polymorphic sites (S) | Number of Haplotypes (h) | Haplotype diversity (Hd) | Nucleotide diversity (Pi) |
|---|---|---|---|---|---|
| Guiyang | 22 | 9 | 3 | 0.255 | 0.00058 |
| Zunyi | 21 | 1 | 2 | 0.181 | 0.00012 |
| Qiannan | 21 | 1 | 2 | 0.181 | 0.00012 |
| Anshun | 21 | 1 | 2 | 0.181 | 0.00012 |
| Qiandongnan | 22 | 2 | 3 | 0.255 | 0.00022 |
| Qianxinan | 21 | 2 | 3 | 0.343 | 0.00023 |
| Liupanshui | 21 | 1 | 2 | 0.324 | 0.00021 |
| Bijie | 21 | 5 | 4 | 0.471 | 0.00046 |
| Tongren | 21 | 9 | 3 | 0.267 | 0.00061 |
| Total | 191 | 10 | 6 | 0.268 | 0.00029 |
| Geographical source | No. of strains | No. of genotypes | No. of isolates for each genotype | |||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |||
| Guiyang | 22 | 3 | 1 | 2 | 19 | |||
| Zunyi | 21 | 2 | 2 | 19 | ||||
| Qiannan | 21 | 2 | 2 | 19 | ||||
| Anshun | 21 | 2 | 2 | 19 | ||||
| Qiandongnan | 22 | 3 | 1 | 2 | 19 | |||
| Qianxinan | 21 | 3 | 2 | 2 | 17 | |||
| Liupanshui | 21 | 2 | 4 | 17 | ||||
| Bijie | 21 | 4 | 1 | 1 | 4 | 15 | ||
| Tongren | 21 | 3 | 1 | 2 | 18 | |||
| Total | 191 | 6 | 2 | 1 | 1 | 3 | 22 | 162 |
| cyp51A gene mutation sites | Itraconazole | Voriconazole | ||
|---|---|---|---|---|
| Correlation Coefficient | p-value | Correlation Coefficient | p-value | |
| 137 | -0.1365 | 0.0597 | 0.0872 | 0.2305 |
| 267 | -0.0605 | 0.4058 | -0.0081 | 0.9118 |
| 514 | 0.1365 | 0.0597 | -0.0872 | 0.2305 |
| 540 | 0.0699 | 0.3365 | -0.0686 | 0.3456 |
| 743 | 0.1365 | 0.0597 | -0.0872 | 0.2305 |
| 744 | -0.0436 | 0.5491 | -0.0101 | 0.8901 |
| 765 | 0.1365 | 0.0597 | -0.0872 | 0.2305 |
| 1074 | 0.0605 | 0.4058 | 0.0081 | 0.9118 |
| 1279 | -0.1365 | 0.0597 | 0.0872 | 0.2305 |
| 1362 | -0.0605 | 0.4058 | -0.0081 | 0.9118 |
| Geographical source | Strain number | MIC( µg/ml) | CYP51A Substitutions (cyp51A gene mutation sites) |
|
|---|---|---|---|---|
| ITR | VOR | |||
| Bijie | BJ-02 | 0.031 | 0.25 | / (267, 540, 1362) |
| BJ-11 | 0.125 | 0.063 | N248K (744) | |
| BJ-12 | 0.125 | 0.063 | / (540) | |
| BJ-13 | 0.125 | 0.063 | N248K (744) | |
| BJ-15 | 0.063 | 0.125 | N248K (744) | |
| BJ-20 | 0.125 | 0.063 | N248K (744) | |
| Zunyi | ZY-06 | 0.063 | 0.063 | N248K (744) |
| ZY-19 | 0.125 | 0.125 | N248K (744) | |
| Qiannan | QN-02 | 0.031 | 0.063 | N248K (744) |
| QN-08 | 0.031 | 0.125 | N248K (744) | |
| Anshun | AS-02 | 0.063 | 0.063 | N248K (744) |
| AS-17 | 0.063 | 0.125 | N248K (744) | |
| Tongren | TR-06 | 0.063 | 0.125 | N248K (744) |
| TR-12 | 0.125 | 0.063 | N248K (744) | |
| TR-21 | 0.125 | 0.063 | F46Y, M172V, N248T, D255E, E427K (137, 267, 514, 743, 765, 1074, 1279, 1362) |
|
| Guiyang | GY-01 | 0.063 | 0.063 | N248K (744) |
| GY-08 | 0.25 | 0.063 | F46Y, M172V, N248T, D255E, E427K (137, 267, 514, 743, 765, 1074, 1279, 1362) |
|
| GY-14 | 0.25 | 0.031 | N248K (744) | |
| Liupanshui | LPS-06 | 0.125 | 0.125 | N248K (744) |
| LPS-07 | 0.063 | 0.063 | N248K (744) | |
| LPS-08 | 0.063 | 0.125 | N248K (744) | |
| LPS-19 | 0.031 | 0.125 | N248K (744) | |
| Qianxinnan | QXN-01 | 0.25 | 0.125 | N248K (744) |
| QXN-09 | 0.015 | 0.063 | N248K (744) | |
| QXN-13 | 0.015 | 0.125 | / (540) | |
| QXN-17 | 0.031 | 0.125 | / (540) | |
| Qiandongnan | QDN-01 | 0.063 | 0.125 | N248K (744) |
| QDN-02 | 0.031 | 0.125 | N248K (744) | |
| QDN-08 | 0.063 | 0.125 | N248K (540, 744) | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).